GLP-1 medications address several of these pathways simultaneously, and stopping treatment may allow the underlying PCOS-driven metabolic dysfunction to reassert itself
These medications include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)
Global GLP-1 receptor agonist market is expected to witness lucrative growth over the forecast period as increasing number of patients are opting for GLP-1 drugs due to their greater efficacy and lesser side effects compared to conventional diabetes medications
This way, your medication can be safely monitored and administered
Side effects can persist after a dose change Because GLP1 levels taper gradually rather than dropping to zero, symptoms can continue for days or even weeks after a dose change
The survey also asked participants whether they would restart taking a GLP-1 if they regain weight after stopping the drug